NewGenIvf Group LtdNIVF
Price (close)
$0.54
Market cap
$1.3M
P/E
0.1x
Revenue (FY)
$4.7M
Net income
$9.9M
Dividend yield
—
1-year total return
-99.9%
Net margin
209.0%
Revenue growth
-13.0%
Debt / equity
—
What NewGenIvf Group Ltd does.
fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely: (i) in vitro fertilization
2024, we generated approximately 82.6% and 100% respectively of our revenue from IVF treatments. We primarily provide our clients with
conventional IVF/intracytoplasmic sperm injection (“ICSI”) and embryo transfer services. As technology has progressively advanced,
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $4.1M | $5.9M | $5.1M | $5.4M | $4.7M |
| Net income | — | -$533 | $458,667 | $130,193 | -$524,643 | $9.9M |
| Free cash flow | — | $1.4M | $1.6M | -$1.8M | -$8.3M | -$11.1M |
More on NIVF.
- NewGenIvf Group Ltd summary
- NewGenIvf Group Ltd financial statements
- NewGenIvf Group Ltd key metrics
- NewGenIvf Group Ltd health scores and style box
- NewGenIvf Group Ltd earnings
- NewGenIvf Group Ltd dividends
- NewGenIvf Group Ltd valuation
- NewGenIvf Group Ltd ownership and insiders
- NewGenIvf Group Ltd peers
Figures from NewGenIvf Group Ltd's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.